Rab11 as a modulator of synaptic transmission

Communicative and Integrative Biology

Volumn 6, Issue 6, 2013, Pages

  Giorgini, Flaviano ^a   Steinert, Joern R ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Huntingtin; Huntington's disease; Neurodegeneration; Rab family GTPases; Rab11; Synapse; Synaptic dysfunction

Indexed keywords

EID: 84894062317     PISSN: 19420889     EISSN: 19420889     Source Type: Journal    
DOI: 10.4161/cib.26807     Document Type: Article

References (45)

1. Picconi B, Piccoli G, Calabresi P. Synaptic dysfunction in Parkinson's disease. Adv Exp Med Biol 2012; 970:553-72; PMID:22351072; http://dx.doi. org/10.1007/978-3-7091-0932-8_24.
2. Milnerwood AJ, Raymond LA. Early synaptic pathophysiology in neurodegeneration: insights from Huntington's disease. Trends Neurosci 2010; 33:513-23; PMID:20850189; http://dx.doi.org/10.1016/j. tins.2010.08.002.
3. Marcello E, Epis R, Saraceno C, Di Luca M. Synaptic dysfunction in Alzheimer's disease. Adv Exp Med Biol 2012; 970:573-601; PMID:22351073; http://dx.doi. org/10.1007/978-3-7091-0932-8_25.
4. Mallucci GR. Prion neurodegeneration: starts and stops at the synapse. Prion 2009; 3:195-201; PMID:19887910; http://dx.doi.org/10.4161/pri.3.4.9981.
5. Ross CA, Tabrizi SJ. Huntington's disease: from molecular pathogenesis to clinical treatment. Lancet Neurol 2011; 10:83-98; PMID:21163446; http://dx.doi.org/10.1016/S1474-4422(10)70245-3.
6. Li X, DiFiglia M. The recycling endosome and its role in neurological disorders. Prog Neurobiol 2012; 97:127-41; PMID:22037413; http://dx.doi. org/10.1016/j.pneurobio.2011.10.002.
7. Pereira-Leal JB, Seabra MC. Evolution of the Rab family of small GTP-binding proteins. J Mol Biol 2001; 313:889-901; PMID:11697911; http://dx.doi. org/10.1006/jmbi.2001.5072.
8. Pfeffer S. Membrane domains in the secretory and endocytic pathways. Cell 2003; 112:507-17; PMID:12600314; http://dx.doi.org/10.1016/S0092-8674(03)00118-1.
9. Khvotchev MV, Ren M, Takamori S, Jahn R, Südhof TC. Divergent functions of neuronal Rab11b in Ca2+-regulated versus constitutive exocytosis. J Neurosci 2003; 23:10531-9; PMID:14627637.
10. Simons K, Zerial M. Rab proteins and the road maps for intracellular transport. Neuron 1993; 11:789-99; PMID:8240804; http://dx.doi. org/10.1016/0896-6273(93)90109-5.
11. Ullrich O, Reinsch S, Urbé S, Zerial M, Parton RG. Rab11 regulates recycling through the pericentriolar recycling endosome. J Cell Biol 1996; 135:913-24; PMID:8922376; http://dx.doi.org/10.1083/jcb.135.4.913.
12. Hales CM, Vaerman JP, Goldenring JR. Rab11 family interacting protein 2 associates with Myosin Vb and regulates plasma membrane recycling. J Biol Chem 2002; 277:50415-21; PMID:12393859; http://dx.doi. org/10.1074/jbc.M209270200.
13. Li X, Valencia A, McClory H, Sapp E, Kegel KB, Difiglia M. Deficient Rab11 activity underlies glucose hypometabolism in primary neurons of Huntington's disease mice. Biochem Biophys Res Commun 2012; 421:727-30; PMID:22542623; http://dx.doi. org/10.1016/j.bbrc.2012.04.070.
14. Li X, Sapp E, Valencia A, Kegel KB, Qin ZH, Alexander J, Masso N, Reeves P, Ritch JJ, Zeitlin S, et al. A function of huntingtin in guanine nucleotide exchange on Rab11. Neuroreport 2008; 19:1643-7; PMID:18845944; http://dx.doi.org/10.1097/WNR.0b013e328315cd4c.
15. Li X, Standley C, Sapp E, Valencia A, Qin ZH, Kegel KB, Yoder J, Comer-Tierney LA, Esteves M, Chase K, et al. Mutant huntingtin impairs vesicle formation from recycling endosomes by interfering with Rab11 activity. Mol Cell Biol 2009; 29:6106-16; PMID:19752198; http://dx.doi.org/10.1128/MCB.00420-09.
16. Li X, Sapp E, Chase K, Comer-Tierney LA, Masso N, Alexander J, Reeves P, Kegel KB, Valencia A, Esteves M, et al. Disruption of Rab11 activity in a knock-in mouse model of Huntington's disease. Neurobiol Dis 2009; 36:374-83; PMID:19699304; http://dx.doi. org/10.1016/j.nbd.2009.08.003.
17. Richards P, Didszun C, Campesan S, Simpson A, Horley B, Young KW, Glynn P, Cain K, Kyriacou CP, Giorgini F, et al. Dendritic spine loss and neurodegeneration is rescued by Rab11 in models of Huntington's disease. Cell Death Differ 2011; 18:191-200; PMID:21217767; http://dx.doi.org/10.1038/cdd.2010.127.
18. del Toro D, Alberch J, Lázaro-Diéguez F, Martín-Ibáñez R, Xifró X, Egea G, Canals JM. Mutant huntingtin impairs post-Golgi trafficking to lysosomes by delocalizing optineurin/Rab8 complex from the Golgi apparatus. Mol Biol Cell 2009; 20:1478-92; PMID:19144827; http://dx.doi.org/10.1091/mbc. E08-07-0726.
19. Ravikumar B, Imarisio S, Sarkar S, O'Kane CJ, Rubinsztein DC. Rab5 modulates aggregation and toxicity of mutant huntingtin through macroautophagy in cell and fly models of Huntington disease. J Cell Sci 2008; 121:1649-60; PMID:18430781; http://dx.doi. org/10.1242/jcs.025726.
20. Giorgini F, Guidetti P, Nguyen Q, Bennett SC, Muchowski PJ. A genomic screen in yeast implicates kynurenine 3-monooxygenase as a therapeutic target for Huntington disease. Nat Genet 2005; 37:526-31; PMID:15806102; http://dx.doi.org/10.1038/ng1542.
21. Mason RP, Casu M, Butler N, Breda C, Campesan S, Clapp J, Green EW, Dhulkhed D, Kyriacou CP, Giorgini F. Glutathione peroxidase activity is neuroprotective in models of Huntington's disease. Nat Genet 2013; 45:1249-54; PMID:23974869; http://dx.doi.org/10.1038/ng.2732.
22. Green EW, Giorgini F. Choosing and using Drosophila models to characterize modifiers of Huntington's disease. Biochem Soc Trans 2012; 40:739-45; PMID:22817726; http://dx.doi.org/10.1042/BST20120072.
23. Steffan JS, Bodai L, Pallos J, Poelman M, McCampbell A, Apostol BL, Kazantsev A, Schmidt E, Zhu YZ, Greenwald M, et al. Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila. Nature 2001; 413:739-43; PMID:11607033; http://dx.doi. org/10.1038/35099568.
24. Romero E, Cha GH, Verstreken P, Ly CV, Hughes RE, Bellen HJ, Botas J. Suppression of neurodegeneration and increased neurotransmission caused by expanded full-length huntingtin accumulating in the cytoplasm. Neuron 2008; 57:27-40; PMID:18184562; http://dx.doi.org/10.1016/j.neuron.2007.11.025.
25. Lee WC, Yoshihara M, Littleton JT. Cytoplasmic aggregates trap polyglutamine-containing proteins and block axonal transport in a Drosophila model of Huntington's disease. Proc Natl Acad Sci U S A 2004; 101:3224-9; PMID:14978262; http://dx.doi. org/10.1073/pnas.0400243101.
26. Labbadia J, Morimoto RI. Huntington's disease: underlying molecular mechanisms and emerging concepts. Trends Biochem Sci 2013; 38:378-85; PMID:23768628; http://dx.doi.org/10.1016/j. tibs.2013.05.003.
27. Krench M, Littleton JT. Modeling Huntington disease in Drosophila: Insights into axonal transport defects and modifiers of toxicity. Fly (Austin) 2013; 7:7; PMID:24022020; http://dx.doi.org/10.4161/fly.26279.
28. Sinadinos C, Burbidge-King T, Soh D, Thompson LM, Marsh JL, Wyttenbach A, Mudher AK. Live axonal transport disruption by mutant huntingtin fragments in Drosophila motor neuron axons. Neurobiol Dis 2009; 34:389-95; PMID:19268537; http://dx.doi.org/10.1016/j.nbd.2009.02.012.
29. Steinert JR, Campesan S, Richards P, Kyriacou CP, Forsythe ID, Giorgini F. Rab11 rescues synaptic dysfunction and behavioural deficits in a Drosophila model of Huntington's disease. Hum Mol Genet 2012; 21:2912-22; PMID:22466800; http://dx.doi. org/10.1093/hmg/dds117.
30. Gadad BS, Britton GB, Rao KS. Targeting oligomers in neurodegenerative disorders: lessons from α-synuclein, tau, and amyloid-β peptide. J Alzheimers Dis 2011; 24(Suppl 2):223-32; PMID:21460436.
31. Sudhof TC. The synaptic vesicle cycle. Annu Rev Neurosci 2004; 27:509-47; PMID:15217342; http://dx.doi.org/10.1146/annurev.neuro.26.041002.131412.
32. Sakane A, Manabe S, Ishizaki H, Tanaka-Okamoto M, Kiyokage E, Toida K, Yoshida T, Miyoshi J, Kamiya H, Takai Y, et al. Rab3 GTPase-activating protein regulates synaptic transmission and plasticity through the inactivation of Rab3. Proc Natl Acad Sci U S A 2006; 103:10029-34; PMID:16782817; http://dx.doi.org/10.1073/pnas.0600304103.
33. Kelly EE, Horgan CP, McCaffrey MW. Rab11 proteins in health and disease. Biochem Soc Trans 2012; 40:1360-7; PMID:23176481; http://dx.doi. org/10.1042/BST20120157.
34. Bhuin T, Roy JK. Rab11 is required for embryonic nervous system development in Drosophila. Cell Tissue Res 2009; 335:349-56; PMID:19015884; http://dx.doi.org/10.1007/s00441-008-0711-8.
35. Satoh AK, O'Tousa JE, Ozaki K, Ready DF. Rab11 mediates post-Golgi trafficking of rhodopsin to the photosensitive apical membrane of Drosophila photoreceptors. Development 2005; 132:1487-97; PMID:15728675; http://dx.doi.org/10.1242/dev.01704.
36. Müller M, Pym EC, Tong A, Davis GW. Rab3-GAP controls the progression of synaptic homeostasis at a late stage of vesicle release. Neuron 2011; 69:749-62; PMID:21338884; http://dx.doi.org/10.1016/j. neuron.2011.01.025.
37. Kawauchi T, Sekine K, Shikanai M, Chihama K, Tomita K, Kubo K, Nakajima K, Nabeshima Y, Hoshino M. Rab GTPases-dependent endocytic pathways regulate neuronal migration and maturation through N-cadherin trafficking. Neuron 2010; 67:588-602; PMID:20797536; http://dx.doi. org/10.1016/j.neuron.2010.07.007.
38. Wickner W, Schekman R. Membrane fusion. Nat Struct Mol Biol 2008; 15:658-64; PMID:18618939; http://dx.doi.org/10.1038/nsmb.1451.
39. Oehlke O, Schlosshardt C, Feuerstein M, Roussa E. Acidosis-induced V-ATPase trafficking in salivary ducts is initiated by cAMP/PKA/CREB pathway via regulation of Rab11b expression. Int J Biochem Cell Biol 2012; 44:1254-65; PMID:22561749; http://dx.doi.org/10.1016/j.biocel.2012.04.018.
40. Oehlke O, Martin HW, Osterberg N, Roussa E. Rab11b and its effector Rip11 regulate the acidosisinduced traffic of V-ATPase in salivary ducts. J Cell Physiol 2011; 226:638-51; PMID:20717956; http://dx.doi.org/10.1002/jcp.22388.
41. Li X, Valencia A, Sapp E, Masso N, Alexander J, Reeves P, Kegel KB, Aronin N, Difiglia M. Aberrant Rab11-dependent trafficking of the neuronal glutamate transporter EAAC1 causes oxidative stress and cell death in Huntington's disease. J Neurosci 2010; 30:4552-61; PMID:20357106; http://dx.doi. org/10.1523/JNEUROSCI.5865-09.2010.
42. Winslow AR, Chen CW, Corrochano S, Acevedo-Arozena A, Gordon DE, Peden AA, Lichtenberg M, Menzies FM, Ravikumar B, Imarisio S, et al. α-Synuclein impairs macroautophagy: implications for Parkinson's disease. J Cell Biol 2010; 190:1023-37; PMID:20855506; http://dx.doi.org/10.1083/jcb.201003122.
43. Greenfield JP, Leung LW, Cai D, Kaasik K, Gross RS, Rodriguez-Boulan E, Greengard P, Xu H. Estrogen lowers Alzheimer beta-amyloid generation by stimulating trans-Golgi network vesicle biogenesis. J Biol Chem 2002; 277:12128-36; PMID:11823458; http://dx.doi.org/10.1074/jbc.M110009200.
44. Dumanchin C, Czech C, Campion D, Cuif MH, Poyot T, Martin C, Charbonnier F, Goud B, Pradier L, Frebourg T. Presenilins interact with Rab11, a small GTPase involved in the regulation of vesicular transport. Hum Mol Genet 1999; 8:1263-9; PMID:10369872; http://dx.doi.org/10.1093/hmg/8.7.1263.
45. Agola JO, Jim PA, Ward HH, Basuray S, Wandinger-Ness A. Rab GTPases as regulators of endocytosis, targets of disease and therapeutic opportunities. Clin Genet 2011; 80:305-18; PMID:21651512; http://dx.doi.org/10.1111/j.1399-0004.2011.01724.x.